DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Print   Email 

Conceptus, Inc. (CPTS)Comments on U.S. Supreme Court Ruling on the Patient Protection and Affordable Care Act of 2010


6/29/2012 10:49:52 AM

MOUNTAIN VIEW, Calif., June 28, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the EssureĀ® procedure, the leading non-surgical permanent birth control method, today announced that as a result of the decision by the U.S. Supreme Court to uphold the majority of the Patient Protection and Affordable Care Act of 2010 (ACA), including the preventive health services provisions, all U.S. Food and Drug Administration approved contraceptive methods including permanent birth control such as the Essure procedure must be made available without cost to womeni in all private insurance plans.

Read at GlobeNewswire

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES